Berlin, July 3, 2023 – Sonic Healthcare Germany has signed an agreement to acquire the Institute for Pathologie & Zytologie Rhein-Sieg. The institute cooperates with several hospitals and numerous phy-sicians in private practice in the region for quality-assured histological, cytological and molecular pathological diagnostics in almost all medical specialties.
The transaction was completed on July 1, 2023. Raue advised Sonic on the regulatory aspects of the transaction.
Raue has been advising Sonic Healthcare extensively on regulatory matters for many years and is assisting with the acquisitions in Germany.
About Sonic Healthcare
Sonic Healthcare is one of the world’s leading providers of medical diagnostic services. The Group offers highly specialized laboratory diagnostics to general practitioners and specialists, as well as to hospitals and non-profit and public healthcare institutions. With around 37,000 employees, Sonic Healthcare is represented worldwide in Australia, New Zealand, England, Ireland, Switzerland, Bel-gium, the USA and Germany.
Advisor to Sonic Healthcare:
Raue, Berlin: Dr. Katharina Wodarz (Partner, Lead, Healthcare, Regulatory), Dr. Nadine Hartung (Partner, Corporate, M&A and Financing), Annette Feißel (Partner, Real Estate and Infrastructure), Judith Heyn (Partner Labour Law), Louise Fußy (Senior Associate, Corporate, M&A and Financing), Emilia Blume (Associate, Labour Law)
Advisors to the Institute for Pathologie & Zytologie Rhein-Sieg: Claus Renzelmann